No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

SonoScape Flagship 4-LED equipped FHD Endoscopy System

Demostrated at Conference "Endoscopy on Air"

Editor: What To Know

  • The latest and much-praised HD-550, a Full-High-Definition video endoscopy system is now paired with a 4-LED light source, setting up a major milestone on SonoScape’s product roadmap.
  • “Plus, the aspect of extensive vascular ectasias in the stomach is clearly revealed, as it becomes much more noticeable under the SFI mode.
  • The new SonoScape Flagship 4-LED equipped FHD Endoscopy System was used in two live demos of the marathonlike endoscopy Live conference.

SonoScape notes on June 5, 2020, “Endoscopy on Air”, an on-line international GI endoscopy conference led by faculties from 23 cities worldwide has attracted more than 20,000 viewers. The event touched upon the full spectrum of diagnostic and therapeutic endoscopy through the live streaming of more than 50 cases. SonoScape participated in the event as the silver sponsor.

SonoScape started as one of the top ultrasound manufacturers globally, but it refused to be limited by its own shadow. Since the establishment of its endoscopy division in 2012, the company keeps up its incredibly fast pace in product development. The latest and much-praised HD-550, a Full-High-Definition video endoscopy system is now paired with a 4-LED light source, setting up a major milestone on SonoScape’s product roadmap. The system delivers a noticeably boosted performance. At every turn, the added brightness allows even more image details, under both White Light or chromoendoscopy SFI/VIST modes.

The new SonoScape Flagship 4-LED equipped FHD Endoscopy System was used in two live demos of the marathonlike endoscopy Live conference. Cases were performed respectively by Prof. Zhou Ping-Hong, a global elite doctor in Shanghai Zhongshan Hospital of Fudan University in China, and Dr. Roberta Maselli in Humanitas Hospital Milan, Italy.

“This is one of the best endoscopic images I have ever seen.” Dr. Maselli commented during her procedure: “Plus, the aspect of extensive vascular ectasias in the stomach is clearly revealed, as it becomes much more noticeable under the SFI mode.”

Facing a transformational time for industry conferences, SonoScape’s new flagship system, HD-550 with 4-LED light source, received high appraisals from the endoscopist community, both online and off.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy